To include your compound in the COVID-19 Resource Center, submit it here.

Idorsia's ACT0541468 meets in Phase II insomnia trials

Idorsia Ltd. (SIX:IDIA) reported data from a pair of Phase II trials in a total of 418 adults and elderly patients with

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE